Director Dealings

Sinclair IS Pharma plc (the "Company")

Director dealings

8 November 2012, Sinclair IS Pharma plc (AIM:SPH.L), the international specialty pharma company, announces that on 7 November 2012, Stuart Swanson, non-executive Director, was awarded 188,850 ordinary shares of 1p each ("Ordinary Shares") in the Company at 28.5 pence per Ordinary Share in lieu of a discretionary bonus. Following this award, Mr Swanson is interested in 3,282,814 Ordinary Shares, representing 0.75% of the issued share capital of the Company.

An application has been made for the 188,850 Ordinary Shares to be admitted to trading on AIM with admission expected to occur on 14 November 2012.

Additional information as required under the AIM Rules

Following this issue of new shares, which rank pari passu with the Company's existing ordinary shares, the Company will have 434,914,773 ordinary 1p shares in issue, each share carrying the right to one vote. The Company does not hold any ordinary shares in Treasury.

The above figure of 434,914,773 ordinary shares may be used by shareholders in the Company as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the share capital of the Company under the Financial Services Authority's Disclosure and Transparency Rules.

For further information please contact: